Detalles de la búsqueda
1.
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
Oncologist
; 25(11): 954-962, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812320
2.
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.
Invest New Drugs
; 37(1): 159-165, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30105668
3.
Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.
Cancer
; 123(19): 3843-3854, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28558150
4.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24173967
5.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711126
6.
Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 28(18): 3979-3989, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35816286
7.
Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors.
J Immunother Cancer
; 10(8)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940825
8.
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
J Clin Oncol
; 39(9): 990-1000, 2021 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33577358
9.
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer.
Clin Transl Sci
; 14(2): 664-670, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340277
10.
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study.
Clin Cancer Res
; 24(16): 3829-3837, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29691300
11.
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.
Eur Urol
; 73(5): 751-759, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29248319
12.
Current immunotherapeutic strategies in colon cancer.
Surg Oncol Clin N Am
; 16(4): 873-900, x, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18022550
13.
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.
J Clin Oncol
; 35(24): 2790-2797, 2017 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28548889
14.
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.
J Clin Oncol
; 35(29): 3338-3346, 2017 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817371
15.
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
J Clin Oncol
; 35(19): 2141-2148, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28291390
16.
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.
Clin Cancer Res
; 23(19): 5711-5719, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679770
17.
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.
Clin Cancer Res
; 21(17): 3870-8, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25944802
18.
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma.
Clin Cancer Res
; 21(15): 3420-7, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25788492
19.
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Eur J Cancer
; 51(14): 1857-64, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26187510
20.
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors.
Cancer Chemother Pharmacol
; 70(1): 95-102, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22638798